Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
Ver/ abrir
Use este enlace para citar
http://hdl.handle.net/2183/37334
A non ser que se indique outra cousa, a licenza do ítem descríbese como Creative Commons Attribution 4.0 International License (CC-BY 4.0)
Coleccións
- Investigación (FCS) [1256]
Metadatos
Mostrar o rexistro completo do ítemTítulo
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West SpainAutor(es)
Data
2020-06-11Cita bibliográfica
Tejada Meza H, Lambea Gil Á, Saldaña AS, Martínez-Zabaleta M, Juez PR, Martínez EL, Apilánez MC, Isasi MH, Enguita JM, Alfonso ML, Arenillas JF, Olaizola JS, Fernández JJT, Sánchez J, Castellanos-Rodrigo M, Roel A, Menéndez IC, Freijo M, Rodriguez AL, Portilla EP, López YJ, Castro ER, Rivas SA, García JT, Rodríguez IB, Julián-Villaverde F, García MPM, Trejo-Gabriel-Galán JM, Iñiguez AE, Juste CT, Lázaro CP, Moreno JM, On Behalf Of The Nordictus Investigators. Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain. Int J Stroke. 2020 Oct;15(7):755-762.
Resumo
[Abstract]
Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital stroke admissions and in-hospital mortality in tertiary referral hospitals from North-West Spain.
Methods: Spanish multicenter retrospective observational study based on data from tertiary hospitals of the NORDICTUS network. We recorded the number of patients admitted for ischemic stroke between 30 December 2019 and 3 May 2020, the number of IVT and EVT procedures, and in-hospital mortality.
Results: In the study period, 2737 patients were admitted with ischemic stroke. There was a decrease in the weekly mean admitted patients during the pandemic (124 vs. 173, p<0.001). In-hospital mortality of stroke patients increased significantly (9.9% vs. 6.5%, p = 0.003), but there were no differences in the proportion of IVT (17.3% vs. 16.1%, p = 0.405) or EVT (22% vs. 23%, p = 0.504).
Conclusion: We found a decrease in the number of ischemic stroke admissions and an increase in in-hospital mortality during the COVID-19 epidemic in this large study from North-West Spain. There were regional changes within the network, not fully explained by the severity of the pandemic in different regions.
Palabras chave
COVID-19
Spain
Stroke
Ischemic stroke
Mortality
Stroke care
Spain
Stroke
Ischemic stroke
Mortality
Stroke care
Descrición
Observational study
Versión do editor
Dereitos
Creative Commons Attribution 4.0 International License (CC-BY 4.0)
ISSN
1747-4930
Ítems relacionados
Mostrando ítems relacionados por Título, autor ou materia.
-
Risk Predictors in a Spanish Cohort With Cardiac Laminopathies. The REDLAMINA Registry
Barriales-Villa, Roberto; Ochoa, Juan Pablo; Larrañaga-Moreira, Jose Maria; Salazar-Mediguchia, Joel; Díez-López, Carles; Restrepo-Córdoba, María Alejandra; Álvarez-Rubio, Jorge; Robles-Mezcua, Ainhoa; Olmo-Conesa, María C.; Nicolás-Rocamora, Elisa; Sanz, Jorge; Villacorta, Eduardo; Gallego-Delgado, María; Yotti, Raquel; Espinosa, María Ángeles; Manovel, Ana; Rincón-Díaz, Luis M.; Jiménez-Jaimez, Juan; Bermúdez-Jiménez, Francisco J.; Basurte-Elorz, M. Teresa; Climent-Payá, Vicente; García-Álvarez, María I.; Rodríguez-Palomares, José Fernando; Limeres-Freire, Javier; Pérez-Guerrero, Ainhoa; Cantero-Pérez, Eva M.; Peña-Peña, Maria Luisa; Palomino-Doza, Julián; Crespo-Leiro, María Generosa; García-Pinilla, José Manuel; Zorio, Esther; Ripoll-Vera, Tomás; García-Pavía, Pablo; Ortiz-Genga, Martín; Monserrat, Lorenzo (Elsevier, 2020-06-29)[Abstract] Introduction and objectives. According to sudden cardiac death guidelines, an implantable cardioverter-defibrillator (ICD) should be considered in patients with LMNA-related dilated cardiomyopathy (DCM) and ... -
Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus: IMMINENT study
Ramos-Araque, María E.; Castellanos, María del Mar; Naya Rios, Lucía; López-Cancio Martínez, Elena; Molina-Gil, Javier; Marta Moreno, Javier; Tejada Meza, Herbert; Temprano-Fernández, María Teresa; Antón-González, Celia; Vidal-de Francisco, Diana; Tejada García, Javier; Maciñeiras Montero, José Luis; Vicente Alba, Pablo; García-Sánchez, Juan Manuel; Aguilera-Irazabal, Borja; Martínez-Zabaleta, Maite; Díez, I.N.; Pinedo Brochado, Ana; Azcune-Calle, Itxaso; Freijo Guerrero, María del Mar; Moreno-Estebanez, A.; Palacio-Portilla, Enrique Jesús; Manrique Arregui, L.; Rodríguez-Yáñez, Manuel; Santamaría Cadavid, María; Timiraos Fernández, Juan José; Herrero-Infante, Yolanda; Trejo-Gabriel-Galán, José María; Echavarría-Iñiguez, Ana; Tejero Juste, Carlos; Rodríguez-Montolio, Joana; Julián Villaverde, Francisco José; Moreno García, María Pilar; López-Mesonero, Luis; Redondo-Robles, Laura; Aymerich, Nuria; Korroza, J.; Arenillas, Juan (Elsevier, 2024-07-03)[Abstract] Background. Our primary aim was to investigate the incidence of non-cardioembolic minor acute ischemic stroke (AIS) and high-risk transient ischemic attack (TIA) and to identify predictors of stroke recurrence/death ... -
Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke
Pérez-Mato, María; Dopico-López, Antonio; Akkoc, Yunus; López-Amoedo, Sonia; Correa-Paz, Clara; Candamio-Lourido, María; Iglesias-Rey, Ramón; López-Arias, Esteban; Bugallo-Casal, Ana; da Silva-Candal, Andrés; Bravo, Susana B.; Chantada-Vázquez, María del Pilar; Arias, Susana; Santamaría-Cadavid, María; Estany-Gestal, Ana; Zagmi, Ahlem; Gauthier, Marc A.; Gutiérrez-Fernández, María; Martin, Abraham; Llop, Jordi; Rodríguez, Cristina; Almeida, Ángeles; Migliavacca, Martina; Polo, Ester; Pelaz, Beatriz; Gozuacik, Devrim; El Yamani, Naouale; SenGupta, Tanima; Rundén-Pran, Elise; Vivancos, José; Castellanos, María del Mar; Díez-Tejedor, Exuperio; Sobrino, Tomás; Rabinkov, Aharon; Mirelman, David; Castillo, José; Campos, Francisco (Cell Press, 2024-11-15)[Summary] The blood enzyme glutamate-oxaloacetate transaminase (GOT) has been postulated as an effective therapeutic to protect the brain during stroke. To demonstrate its potential clinical utility, a new human recombinant ...